Actively Recruiting
External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Cholecystectomy
Led by Karabuk University · Updated on 2026-01-30
60
Participants Needed
2
Research Sites
14 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled study aims to compare the effects of the external oblique intercostal block (EOIB) and the erector spinae plane block (ESPB) on postoperative analgesia in adult patients undergoing elective laparoscopic cholecystectomy. Both EOIB and ESPB are ultrasound-guided regional anesthesia techniques currently used in clinical practice to improve postoperative pain control as part of multimodal analgesia strategies. Laparoscopic cholecystectomy is a common minimally invasive surgical procedure; however, patients may still experience postoperative pain that can increase opioid consumption and delay recovery. Identifying the most effective regional anesthesia technique may improve postoperative analgesia and patient recovery. In this study, eligible patients will be randomly assigned to receive either bilateral EOIB or bilateral ESPB in addition to standardized general anesthesia and postoperative patient-controlled analgesia. Postoperative pain scores, opioid consumption, quality of recovery, postoperative nausea and vomiting, and block-related complications will be evaluated during the first 24 hours after surgery. The study aims to provide comparative clinical evidence regarding the analgesic effectiveness of these two regional anesthesia techniques.
CONDITIONS
Official Title
External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Cholecystectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Scheduled to undergo elective laparoscopic cholecystectomy
- Classified as American Society of Anesthesiologists (ASA) physical status I-III
- Ability to understand and operate a patient-controlled analgesia (PCA) device
- Provision of written informed consent
You will not qualify if you...
- History of chronic opioid use for more than four weeks prior to surgery
- Presence of pre-existing chronic pain conditions, such as migraine or fibromyalgia
- History of alcohol or substance abuse
- Known hypersensitivity or allergy to local anesthetics or opioids
- Presence of severe organ dysfunction, including clinically significant hepatic or renal disease
- Any contraindication to regional anesthesia
- Severe psychiatric disorders impairing patient cooperation or the ability to reliably assess pain (e.g., psychosis, dementia)
- Pregnancy or breastfeeding
- Presence of hematological disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Karabuk Training and Research Hospital, Department of Anesthesiology and Reanimation
Karabük, Turkey (Türkiye), 78200
Actively Recruiting
2
Department of Anesthesiology and Reanimation, Samsun City Hospital
Samsun, Turkey (Türkiye), 55200
Actively Recruiting
Research Team
E
Elif Sarikaya Ozel, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here